Deep Genomics

Thank you, Michael Eisenstein at Nature Magazine, for diving into the latest breakthrough in biology, AI foundation models. At Deep Genomics, we are finding new ways of accelerating discoveries in drug development and biotechnology leveraging the vast datasets of genetic, molecular, and cellular data these AI models can process. Not only does this innovation reshape how we approach complex challenges like disease diagnosis, it also sets the groundwork for personalized medicine and in turn, creates better patient outcomes. Brendan Frey was happy to contribute his expertise to the piece. A few of his thoughts below: “'A year and a half ago in our pitch, we would proudly talk about how we had 40 different machine learning models,' says Brendan Frey, founder and chief innovation officer of RNA drug discovery company Deep Genomics. Maintaining, scaling and integrating disparate models for predicting distinct yet intersecting biological processes such as RNA transcription, splicing or polyadenylation proved too challenging, however. As a solution, the company developed BigRNA, a foundation model that can make robust predictions about all these aspects of RNA biology — and more." "As more researchers begin to tinker with the models, Frey envisions opportunities ranging from accelerated discovery of new drugs for ultra-rare diseases to ‘multimodal’ models that integrate data from DNA, RNA, and protein to produce a more holistic perspective on the cellular interior. 'Eventually, I would hope we’ll start peeling back the cover on systems biology.'” To read more, check out the full article here 👉https://lnkd.in/eNv6nfPY #techbio #biology #DrugDiscovery #AIinnovation

It’s an exciting day at Deep Genomics! We are thrilled to welcome two new faces to our team. Shawdee Eshghi is joining Deep Genomics as Vice President, Platform Biology and Monika Kowalczyk, MD PhD, as our Vice President of Platform Technology. They will be working out of our Cambridge office, leading our development teams across our US and Canada offices. To learn more about their role and background, click the link👇 https://lnkd.in/gZMW5h8D Please give them a warm welcome below 🎉 #NewHire #EmployeeSpotlight #LifeatDeepGenomics

It’s an exciting day at Deep Genomics! We are thrilled to announce two new additions to the team. Shawdee Eshghi is joining Deep Genomics as Vice President, Platform Biology and Monika Kowalczyk, MD PhD as our Vice President of Platform Technology. They will be working out of our Cambridge office, leading our development teams across our US and Canada offices. To learn more about their role and background, click the link below 👇 https://lnkd.in/gZMW5h8D Please give them a warm welcome below 🎉 #NewHire #EmployeeSpotlight #LifeatDeepGenomics

We're #hiring a new Research Associate, Pooled and Arrayed Screening (Multiple Levels) in Toronto, Ontario. Apply today or share this post with your network.

We're #hiring a new Principal Scientist, Platform Technology in Cambridge, Massachusetts. Apply today or share this post with your network.

On World Health Day, we are reminded why innovation in drug discovery matters. This year’s theme, "Healthy Beginnings, Hopeful Futures," encourages efforts to prioritize newborn and women’s health 🤱 At Deep Genomics, we are committed not only to using AI to accelerate drug discovery but also to advancing the development of life-changing therapies. By making drug development smarter, faster, and more precise, we are working toward a future where more people receive the treatments they need when they need them. Innovation is shaping the future of medicine, and we’re proud to be part of this movement 💊 #WorldHealthDay #AIforGood #DrugDiscovery 

It’s been a busy start to the year at Deep Genomics! Our team has already attended four events, and there are many more to come. Here’s a quick recap of where we’ve been so far: 🏥 The 43rd Annual J.P. Morgan Healthcare Conference in San Francisco 🧬 The 2025 Front Line Genomics Festival of Genomics and Biodata in London, UK  🖥️ The March Edition of MicroSummits: AI in Drug Discovery hosted virtually  💊 The 2025 D2R | DNA to RNA Research Symposium in Montreal, Quebec Any guesses on where the team is headed next? (We may have spoiled it yesterday!) 🌎 #DrugDiscovery #Conferences #LifeatDeepGenomics 

Informa Connect's #TIDESUSA conference is back for 2025! This year, our CIO and Co-founder Brendan Frey will be on stage to present his talk: Foundation Models: A New Hope For Emergent Drug Discovery Intelligence. Brendan’s session will explore whether we are on the brink of emergent intelligence in drug discovery, driven by advancements in AI foundation models. Our AI foundation models are trained on multiple datasets that understand broad areas of both biology and chemistry, enabling predictions across a wide range of drug discovery tasks. Join us at Brendan’s session on May 19th to learn more! We can’t wait to see you there 🧬 https://lnkd.in/gC3X8W9U #AI #DrugDiscovery #TechBio #TIDESUSA

Welcome to another instalment of our #CoreValues series! Today, we are deep diving into the C in our ACES – Collaborate Seamlessly 🤝 For us, this means not only working together to achieve common goals, but also taking the time to understand each other’s work so we can connect the dots across the organization. Everyone brings a unique skill set to the table and it’s important we recognize and celebrate these strengths when we come together as a team. Collaborating seamlessly also reminds us to ask for help when we need it. Jumping in and supporting one another is how we win 🎯    These #CoreValues guide our work every day so stay tuned for more of this series in the coming weeks!     #LifeAtDeepGenomics #Team #Collaboration #Innovation  

A few weeks ago, our CIO and co-founder, Brendan Frey, presented at the AI in Drug Discovery MicroSummits alongside other leaders in biotech and AI science. His lightning talk, “AI in Drug Discovery Advances,” offers a bite-sized deep dive into the innovations and advancements our team has been working on. If you have a few minutes, give it a listen and let us know what you took away 👂 #MicroSummit #AIInnovation #DrugDiscovery #LightningTalks